Challenges and misconceptions in the aetiology and management of atrial fibrillation-related strokes

European Journal of Internal Medicine

Volumn 26, Issue 7, 2015, Pages 461-467

  Thijs, V ^a,b,c   Butcher, K ^d  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^c UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^d UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Anticoagulation; Atrial fibrillation; Stroke; Thromboembolism

Indexed keywords

ANTICOAGULANT AGENT; FIBRINOLYTIC AGENT; VITAMIN K GROUP; WARFARIN;

ANTICOAGULANT THERAPY; ATRIAL FIBRILLATION; BRAIN HEMORRHAGE; BRAIN INFARCTION; BRAIN ISCHEMIA; CARDIAC PATIENT; CEREBROVASCULAR ACCIDENT; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; GENERAL PRACTITIONER; HIGH RISK PATIENT; HUMAN; PREVALENCE; PROGNOSIS; RETREATMENT; REVIEW; STROKE PATIENT; THERAPEUTIC MISCONCEPTION; TIME TO TREATMENT; TRANSIENT ISCHEMIC ATTACK; ANTAGONISTS AND INHIBITORS; CLASSIFICATION; COMPLICATION; DISEASE MANAGEMENT; ISCHEMIC ATTACK, TRANSIENT; STROKE;

ANTICOAGULANTS; ATRIAL FIBRILLATION; DISEASE MANAGEMENT; FIBRINOLYTIC AGENTS; HUMANS; ISCHEMIC ATTACK, TRANSIENT; PROGNOSIS; STROKE; VITAMIN K; WARFARIN;

EID: 84941599506     PISSN: 09536205     EISSN: 18790828     Source Type: Journal    
DOI: 10.1016/j.ejim.2015.06.008     Document Type: Review

References (49)

1. D.M. Lloyd-Jones, T.J. Wang, E.P. Leip, M.G. Larson, D. Levy, R.S. Vasan, and et al. Lifetime risk for development of atrial fibrillation: the Framingham Heart Study Circulation 110 2004 1042 1046
2. T.J. Wang, J.M. Massaro, D. Levy, R.S. Vasan, P.A. Wolf, R.B. D'Agostino, and et al. A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: the Framingham Heart Study JAMA 290 2003 1049 1056
3. T. Vanassche, M.N. Lauw, J.W. Eikelboom, J.S. Healey, R.G. Hart, M. Alings, and et al. Risk of ischaemic stroke according to pattern of atrial fibrillation: analysis of 6563 aspirin-treated patients in ACTIVE-A and AVERROES Eur Heart J 36 2015 281 288
4. R. Hart, L. Pearce, and J. Halperin Comparison of 12 risk stratification schemes to predict stroke in patients with nonvalvular atrial fibrillation Stroke 39 2008 1901 1910
5. S.E. Vermeer, W.T. Longstreth Jr., and P.J. Koudstaal Silent brain infarcts: a systematic review Lancet Neurol 6 2007 611 619
6. S. Udompanich, G.Y. Lip, S. Apostolakis, and D.A. Lane Atrial fibrillation as a risk factor for cognitive impairment: a semi-systematic review QJM 106 2013 795 802
7. S. Seshadri, and P.A. Wolf Lifetime risk of stroke and dementia: current concepts, and estimates from the Framingham Study Lancet Neurol 6 2007 1106 1114
8. K.K. Andersen, T.S. Olsen, C. Dehlendorff, and L.P. Kammersgaard Hemorrhagic and ischemic strokes compared: stroke severity, mortality, and risk factors Stroke 40 2009 2068 2072
9. D. Mozaffarian, E.J. Benjamin, A.S. Go, D.K. Arnett, M.J. Blaha, M. Cushman, and et al. Heart disease and stroke statistics-2015 update: a report from the american heart association Circulation 131 2015 e29 e322
10. H.C. Diener, S.J. Connolly, and J.D. Easton Rationale, Objectives and Design of a Secondary Stroke Prevention Study of Dabigatran Etexilate Versus Acetylsalicylic Acid in Patients With Embolic Stroke of Undetermined Source (RE-SPECT ESUS) 23rd European Stroke Conference May 6 2014
11. M.R. Patel, K.W. Mahaffey, J. Garg, G. Pan, D.E. Singer, W. Hacke, and et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation N Engl J Med 365 2011 883 891
12. S.J. Connolly, M.D. Ezekowitz, S. Yusuf, J. Eikelboom, J. Oldgren, A. Parekh, and et al. Dabigatran versus warfarin in patients with atrial fibrillation N Engl J Med 361 2009 1139 1151
13. C.B. Granger, J.H. Alexander, J.J. McMurray, R.D. Lopes, E.M. Hylek, M. Hanna, and et al. Apixaban versus warfarin in patients with atrial fibrillation N Engl J Med 365 2011 981 992
14. V.L. Feigin, M.H. Forouzanfar, R. Krishnamurthi, G.A. Mensah, M. Connor, D.A. Bennett, and et al. Global and regional burden of stroke during 1990-2010: findings from the Global Burden of Disease Study 2010 Lancet 383 2014 245 254
15. R.L. Sacco, S.E. Kasner, J.P. Broderick, L.R. Caplan, J.J. Connors, A. Culebras, and et al. An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association Stroke 44 2013 2064 2089
16. S.C. Johnston, D.R. Gress, W.S. Browner, and S. Sidney Short-term prognosis after emergency department diagnosis of TIA JAMA 284 2000 2901 2906
17. A.I. Qureshi, A.D. Mendelow, and D.F. Hanley Intracerebral haemorrhage Lancet 373 2009 1632 1644
18. N. Wahlgren, N. Ahmed, A. Davalos, G.A. Ford, M. Grond, W. Hacke, and et al. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study Lancet 369 2007 275 282
19. M. Fiorelli, S. Bastianello, K.R. von, G.J. del Zoppo, V. Larrue, E. Lesaffre, and et al. Hemorrhagic transformation within 36 hours of a cerebral infarct: relationships with early clinical deterioration and 3-month outcome in the European Cooperative Acute Stroke Study I (ECASS I) cohort Stroke 30 1999 2280 2284
20. D.S. Conway, L.A. Pearce, B.S. Chin, R.G. Hart, and G.Y. Lip Plasma von Willebrand factor and soluble p-selectin as indices of endothelial damage and platelet activation in 1321 patients with nonvalvular atrial fibrillation: relationship to stroke risk factors Circulation 106 2002 1962 1967
21. B. Freestone, G.Y. Lip, A.Y. Chong, S. Nadar, K.W. Lee, and A.D. Blann Circulating endothelial cells in atrial fibrillation with and without acute cardiovascular disease Thromb Haemost 94 2005 702 706
22. R.G. Hart, and J.L. Halperin Atrial fibrillation and stroke: concepts and controversies Stroke 32 2001 803 808
23. R.G. Hart, L.A. Pearce, V.T. Miller, D.C. Anderson, J.F. Rothrock, G.W. Albers, and et al. Cardioembolic vs. noncardioembolic strokes in atrial fibrillation: frequency and effect of antithrombotic agents in the stroke prevention in atrial fibrillation studies Cerebrovasc Dis 10 2000 39 43
24. G. Potter, F. Doubal, C. Jackson, C. Sudlow, M. Dennis, and J. Wardlaw Associations of clinical stroke misclassification ('clinical-imaging dissociation') in acute ischemic stroke Cerebrovasc Dis 29 2010 395 402
25. R.P. Gerraty, M.W. Parsons, P.A. Barber, D.G. Darby, P.M. Desmond, B.M. Tress, and et al. Examining the lacunar hypothesis with diffusion and perfusion magnetic resonance imaging Stroke 33 2002 2019 2024
26. N. Asdaghi, B. Hameed, M. Saini, T. Jeerakathil, D. Emery, and K. Butcher Acute perfusion and diffusion abnormalities predict early new MRI lesions 1 week after minor stroke and transient ischemic attack Stroke 42 2011 2191 2195
27. P. Amarenco, J. Bogousslavsky, L.R. Caplan, G.A. Donnan, and M.G. Hennerici New approach to stroke subtyping: the A-S-C-O (phenotypic) classification of stroke Cerebrovasc Dis 27 2009 502 508
28. C.A. Jackson, A. Hutchison, M.S. Dennis, J.M. Wardlaw, A. Lindgren, B. Norrving, and et al. Differing risk factor profiles of ischemic stroke subtypes: evidence for a distinct lacunar arteriopathy? Stroke 41 2010 624 629
29. P.E. Cotter, P.J. Martin, L. Ring, E.A. Warburton, M. Belham, and P.J. Pugh Incidence of atrial fibrillation detected by implantable loop recorders in unexplained stroke Neurology 80 2013 1546 1550
30. T. Sanna, H.C. Diener, R.S. Passman, L.V. Di, R.A. Bernstein, C.A. Morillo, and et al. Cryptogenic stroke and underlying atrial fibrillation N Engl J Med 370 2014 2478 2486
31. D.J. Gladstone, M. Spring, P. Dorian, V. Panzov, K.E. Thorpe, J. Hall, and et al. Atrial fibrillation in patients with cryptogenic stroke N Engl J Med 370 2014 2467 2477
32. J.S. Healey, S.J. Connolly, M.R. Gold, C.W. Israel, I.C. Van Gelder, A. Capucci, and et al. Subclinical atrial fibrillation and the risk of stroke N Engl J Med 366 2012 120 129
33. R.G. Hart, H.C. Diener, S.B. Coutts, J.D. Easton, C.B. Granger, M.J. O'Donnell, and et al. Embolic strokes of undetermined source: the case for a new clinical construct Lancet Neurol 13 2014 429 438
34. M. Brambatti, S.J. Connolly, M.R. Gold, C.A. Morillo, A. Capucci, C. Muto, and et al. Temporal relationship between subclinical atrial fibrillation and embolic events Circulation 129 2014 2094 2099
35. P. Sandercock, J. Bamford, M. Dennis, J. Burn, J. Slattery, L. Jones, and et al. Atrial fibrillation and stroke: prevalence in different types of stroke and influence on early and long term prognosis (Oxfordshire community stroke project) BMJ 305 1992 1460 1465
36. H.J. Lin, P.A. Wolf, M. Kelly-Hayes, A.S. Beiser, C.S. Kase, E.J. Benjamin, and et al. Stroke severity in atrial fibrillation. The Framingham Study Stroke 27 1996 1760 1764
37. C. Steger, A. Pratter, M. Martinek-Bregel, M. Avanzini, A. Valentin, J. Slany, and et al. Stroke patients with atrial fibrillation have a worse prognosis than patients without: data from the Austrian Stroke registry Eur Heart J 25 2004 1734 1740
38. V. Thijs More bad news about atrial fibrillation Eur Heart J 25 2004 1670 1671
39. M. O'Donnell, W. Oczkowski, J. Fang, C. Kearon, J. Silva, C. Bradley, and et al. Preadmission antithrombotic treatment and stroke severity in patients with atrial fibrillation and acute ischaemic stroke: an observational study Lancet Neurol 5 2006 749 754
40. H.C. Diener, E. Marijon, and J. Le Huezey Recurrent events and mortality among atrial fibrillation patients treated with dabigatran or warfarin in the RELY trial 22nd European Stroke Conference May 28 2013
41. A.E. Warkentin, M.P. Donadini, F.A. Spencer, W. Lim, and M. Crowther Bleeding risk in randomized controlled trials comparing warfarin and aspirin: a systematic review and meta-analysis J Thromb Haemost 10 2012 512 520
42. R.G. Hart, B.S. Boop, and D.C. Anderson Oral anticoagulants and intracranial hemorrhage. Facts and hypotheses Stroke 26 1995 1471 1477
43. R.G. Hart, H.C. Diener, S. Yang, S.J. Connolly, L. Wallentin, P.A. Reilly, and et al. Intracranial hemorrhage in atrial fibrillation patients during anticoagulation with warfarin or dabigatran: the RE-LY trial Stroke 43 2012 1511 1517
44. T.G. Phan, M. Koh, and E.F. Wijdicks Safety of discontinuation of anticoagulation in patients with intracranial hemorrhage at high thromboembolic risk Arch Neurol 57 2000 1710 1713
45. S.C. Cannegieter, F.R. Rosendaal, and E. Briet Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses Circulation 89 1994 635 641
46. M.H. Eckman, J. Rosand, K.A. Knudsen, D.E. Singer, and S.M. Greenberg Can patients be anticoagulated after intracerebral hemorrhage? A decision analysis Stroke 34 2003 1710 1716
47. D.R. Holmes, V.Y. Reddy, Z.G. Turi, S.K. Doshi, H. Sievert, M. Buchbinder, and et al. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial Lancet 374 2009 534 542
48. W.N. Whiteley, H.P. Adams Jr., P.M. Bath, E. Berge, P.M. Sandset, M. Dennis, and et al. Targeted use of heparin, heparinoids, or low-molecular-weight heparin to improve outcome after acute ischaemic stroke: an individual patient data meta-analysis of randomised controlled trials Lancet Neurol 12 2013 539 545
49. E.C. Jauch, J.L. Saver, H.P. Adams Jr., A. Bruno, J.J. Connors, B.M. Demaerschalk, and et al. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association Stroke 44 2013 870 947